The emerging roles of N6-methyladenosine RNA methylation in human cancers

Huafei Shen,Yifen Lan,Yanchun Zhao,Yuanfei Shi,Jie Jin,Wanzhuo Xie

DOI: https://doi.org/10.1186/s40364-020-00203-6

2020-01-01

Biomarker Research

Abstract:N6-methyladenosine (m 6 A) is the most abundant form of mRNA modification in eukaryotes. It affects various aspects of RNA metabolism, including nuclear export, translation, decay and alternative splicing. In addition, m 6 A also participates in a great number of human physiological processes, ranging from spermatogenesis modulation, response to heat shock, the control of T cell homeostasis to stem cell proliferation and differentiation. The dynamic equilibrium of m 6 A level is regulated by m 6 A methyltransferases (“writers”), m 6 A demethylases (“erasers”) as well as m 6 A-binding proteins (“readers”). Once the balance is broken, numerous diseases will knock on the door. Recently, increasing studies reveal that m 6 A methylation exerts a profound impact on tumorigenesis and tumor progression. Therefore, in this review, we summarize the functions of m 6 A modification and its emerging roles in human cancers, and discuss the potential of m 6 A regulators as biomarkers or therapeutic targets.